A detailed history of Leigh Baldwin & Co., LLC transactions in Organon & Co. stock. As of the latest transaction made, Leigh Baldwin & Co., LLC holds 12,496 shares of OGN stock, worth $109,589. This represents 0.15% of its overall portfolio holdings.

Number of Shares
12,496
Previous 15,746 20.64%
Holding current value
$109,589
Previous $235 Million 20.79%
% of portfolio
0.15%
Previous 0.2%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 13, 2025

SELL
$14.29 - $16.41 $46,442 - $53,332
-3,250 Reduced 20.64%
12,496 $186 Million
Q4 2024

Feb 25, 2025

SELL
$14.44 - $18.83 $3.1 Million - $4.05 Million
-214,953 Reduced 93.17%
15,746 $235 Million
Q4 2024

Feb 14, 2025

BUY
$14.44 - $18.83 $3.33 Million - $4.34 Million
230,699 New
230,699 $231 Million

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $2.23B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Leigh Baldwin & Co., LLC Portfolio

Follow Leigh Baldwin & Co., LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Leigh Baldwin & Co., LLC, based on Form 13F filings with the SEC.

News

Stay updated on Leigh Baldwin & Co., LLC with notifications on news.